AUREUM DIAGNOSTICS LIMITED
Research and experimental development on biotechnology
AUREUM DIAGNOSTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Full company profile for AUREUM DIAGNOSTICS LIMITED (13201459), an active life sciences and medical technology company based in United Kingdom. Incorporated 15 Feb 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Cash in Bank
£277.97k
Net Assets
£293.07k
Total Liabilities
£307.68k
Turnover
N/A
Employees
14
Debt Ratio
51%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (2)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | May 2022 | Seed |
| Investor 2 | May 2022 | Seed |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Hegarty, Mark, Dr | Director | British | United Kingdom | 6 Mar 2024 | Active |
See all 11 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Damion Kevin Corrigan
British
- Ownership Of Shares 50 To 75 Percent
Norcliffe Capital Limited
Ceased 10 Feb 2025
Patricia Elaine Reynolds
Ceased 8 Oct 2021
University Of Strathclyde
Ceased 14 Oct 2021
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 1 Apr 2026 | Capital | Allotment of shares (GBP 42,686.7) on 31 Mar 2026 | |
| 1 Apr 2026 | Confirmation Statement | Confirmation statement made on 14 Feb 2026 with updates | |
| 23 Sept 2025 | Accounts | Annual accounts made up to 31 Mar 2025 | |
| 4 Apr 2025 | Capital | Allotment of shares (GBP 4,280,663.492800) on 2 Apr 2025 | |
| 4 Apr 2025 | Capital | Allotment of shares (GBP 40,039.190) on 2 Apr 2025 |
Allotment of shares (GBP 42,686.7) on 31 Mar 2026
Confirmation statement made on 14 Feb 2026 with updates
Annual accounts made up to 31 Mar 2025
Allotment of shares (GBP 4,280,663.492800) on 2 Apr 2025
Allotment of shares (GBP 40,039.190) on 2 Apr 2025
Recent Activity
Latest Activity
Allotment of shares (GBP 42,686.7) on 31 Mar 2026
1 months ago on 1 Apr 2026
Confirmation statement made on 14 Feb 2026 with updates
1 months ago on 1 Apr 2026
Annual accounts made up to 31 Mar 2025
7 months ago on 23 Sept 2025
Allotment of shares (GBP 4,280,663.492800) on 2 Apr 2025
1 years ago on 4 Apr 2025
Allotment of shares (GBP 40,039.190) on 2 Apr 2025
1 years ago on 4 Apr 2025